There are many active research projects accessing and applying shared ADNI data. Use the search above to find specific research focuses on the active ADNI investigations. This information is requested annually as a requirement for data access.
| Principal Investigator | |
| Principal Investigator's Name: | Qiang Qiang |
| Institution: | Fudan University |
| Department: | Department of Neurology |
| Country: | |
| Proposed Analysis: | Alzheimer disease (AD) pathology is characterized by Amyloid-β (Aβ) plaques and tau neurofibrillary tangles, which are two neuropathological hallmarks of AD. Those AD pathology in living patients can be visualized in vivo by amyloid PET and tau PET. We want to utilize the data from ADNI cohort to explore the association of patient’s demographic, clinical, APOE genotype, MRI, genetic, neuropsychological tests, cerebrospinal fluid and other biochemical biomarkers information with their amyloid and tau pathology. We want to identify practical ways to track the disease progression of AD patients. |
| Additional Investigators | |
| Investigator's Name: | Hiroaki Adachi |
| Proposed Analysis: | Alzheimer disease (AD) pathology is characterized by Amyloid-β (Aβ) plaques and tau neurofibrillary tangles, which are two neuropathological hallmarks of AD. Those AD pathology in living patients can be visualized in vivo by amyloid PET and tau PET. We want to utilize the data from ADNI cohort to explore the association of patient’s demographic, clinical, APOE genotype, MRI, genetic, neuropsychological tests, cerebrospinal fluid and other biochemical biomarkers information with their amyloid and tau pathology. We want to identify practical ways to track the disease progression of AD patients. |
